Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
Study Information
Alliance Study ID: A091103
NCT Study ID (ClinicalTrials.gov): NCT01623869
Alliance Committee: Experimental Therapeutics
Disease or Cancer Type: Sarcoma & Soft Tissue / Bone Cancers
Alliance Study Chair: Sandra D'Angelo
Status: COMPLETED
Study Description
This phase II trial studies how well trebananib works in treating patients with advanced angiosarcoma that cannot be removed by surgery. Trebananib may stop the growth of tumor cells by blocking blood flow to the tumor.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information